Ada Symptom Assessment
AI-powered symptom assessment optimized by clinicians
Company profile
Company profile
Ada Health is a digital health company that provides AI-powered symptom assessment and health information services. The company's flagship product is an AI-driven symptom checker that has been optimized by clinicians to help users understand their health concerns. Ada combines artificial intelligence with medical expertise to deliver personalized health assessments accessible through a mobile app. The platform features a comprehensive Medical Library containing easy-to-understand health information, tips for wellness, and detailed explanations of conditions and symptoms. All content is created by doctors and grounded in the latest medical research. Ada serves both individual consumers through its app and partners with healthcare organizations to integrate its technology into their services. The company's mission is to empower people with good health information that leads to better health choices. Ada's approach combines advanced AI technology with clinical validation to provide reliable, accessible health guidance that helps users make informed decisions about their care.
Company description ADM Diagnostics official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-powered symptom assessment optimized by clinicians
Easy-to-understand health information created by doctors
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Alzheimer's & dementia : the journal of the Alzheimer's Association · May 1, 2026
Plasma p-tau217 and glucose metabolism correlate in neocortical association areas in Alzheimer's disease.Brain communications · Jan 1, 2026
Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expression.European journal of nuclear medicine and molecular imaging · Jan 1, 2026
EC50 images reveal reproducible spatial variation in drug affinity across single- and repeat-dose occupancy studies.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · Nov 1, 2025
Sex-specific associations of serum testosterone with gray matter volume and cerebral blood flow in midlife individuals at risk for Alzheimer's disease.PloS one · Jan 1, 2025
In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology.Scientific reports · Jun 20, 2024
Clinical validation
NCT04838301 · Sponsor · ACTIVE NOT RECRUITING
PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and CognitionNCT05664477 · Sponsor · ACTIVE NOT RECRUITING
Regulatory
K193287 · 510k · Nov 20, 2020
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Through provision of good health information
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on ADM Diagnostics's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-enhanced telemedicine platforms, virtual care delivery systems, AI-powered triage, or virtual health assistants that facilitate remote clinical consultations between patients and healthcare providers. Includes integrated telehealth platforms with AI capabilities for scheduling, triage, and follow-up care.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.